Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
1.
Mar Environ Res ; 151: 104774, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31500813

ABSTRACT

A multimetric approach was used to detect structural, compositional, and functional shifts in the underlying macrobenthic communities of an offshore mussel (Mytilus galloprovincialis) farm in a Portuguese Aquaculture Production Area. Sampling stations distributed inside and outside this area were used to evaluate sediment descriptors and macrobenthic samples collected before (April and September 2010) and after (June and September 2014) the initiation of mussel farming. Sediment fine fraction, organic matter content, and trace element concentrations were found to increase with depth, independently from the mussel farm. Moreover, the structure and composition of the macrobenthic communities were likewise structured by depth. Turnover was the dominant temporal and spatial pattern of beta diversity for all communities. Furthermore, the functional diversity of these communities was unaffected by the mussel farm. These results suggested that an offshore profile allowed hydrodynamic conditions to weaken the impact of mussel farming and highlighted the importance of conducting an integrative multimetric analysis when studying aquaculture impacts on benthic communities.


Subject(s)
Aquaculture , Mytilus , Animals , Ecosystem , Geologic Sediments , Seafood
2.
Pediatr Transplant ; 18(5): E169-73, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24930454

ABSTRACT

Fungal respiratory infections in patients with CF are a significant concern both pre- and post-lung transplantation (LTx). Fungal infection is associated with increased mortality post-LTx, and in the past decade, the prevalence of fungal colonization in Canadian pediatric patients with CF has increased. The emergence of novel fungal pathogens is particularly challenging to the transplant community, as little is known regarding their virulence and optimal management. We present a case of a successful double-lung transplant in a pediatric patient with CF who was infected pretransplantation with a novel yeast, Blastobotrys rhaffinosifermentans. This patient was treated successfully with aggressive antifungal therapy post-transplantation, followed by extended fungal prophylaxis. The significance of fungal colonization and infection in children with CF pre- and post-LTx is reviewed.


Subject(s)
Cystic Fibrosis/therapy , Lung Transplantation , Mycoses/therapy , Antifungal Agents/therapeutic use , Ascomycota , Bronchoscopy , Canada , Child , Cystic Fibrosis/complications , Forced Expiratory Volume , Humans , Inflammation , Lung/microbiology , Lung/pathology , Male , Microbial Sensitivity Tests , Mycoses/complications , Postoperative Complications , Treatment Outcome
3.
Am J Transplant ; 12(11): 3152-4, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22900907

ABSTRACT

Diarrhea is a common manifestation of disease in recipients of intestinal transplants. Sodium Polystyrene Sulfonate administration has been associated with significant bowel injury. Recognizing the diagnosis requires clinical awareness and comprehensive review of intestinal biopsies. We present an illustrative case and discussion. It is the first reported case in a pediatric intestinal transplant patient with serial intestinal biopsies documenting the evolution of disease.


Subject(s)
Ileum/transplantation , Intestinal Mucosa/pathology , Organ Transplantation/adverse effects , Polystyrenes/administration & dosage , Polystyrenes/adverse effects , Biopsy, Needle , Child, Preschool , Diarrhea/diagnosis , Diarrhea/etiology , Emergency Service, Hospital , Follow-Up Studies , Humans , Ileostomy/adverse effects , Ileostomy/methods , Ileum/pathology , Immunohistochemistry , Intestinal Mucosa/drug effects , Male , Necrosis/chemically induced , Necrosis/pathology , Organ Transplantation/methods , Risk Assessment
4.
Lupus ; 18(9): 813-21, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19578106

ABSTRACT

We present long-term outcomes of BXSB mice after non-myeloablative bone marrow transplants using major histocompatability complex (MHC)-matched cells. Groups differed in sources of donor lymphocytes or mesenchymal stromal cells (MSC). Unfractionated marrow cells from green fluorescent protein (GFP) transgenic (Tg) mice (BMT group) or from RAG1-/- B6 mice (RAG group) were injected intravenously (i.v.) into irradiated (550 cGy) hosts. As a source of mesenchymal cells, bone chips from GFP-Tg were injected intraperitoneally alone (MSC group) or along with i.v. bone marrow cells (BMT + MSC group). Controls were untreated mice (UnTx) or mice exposed to radiation only (Rad Cont). At 62 weeks post-transplant, surviving mice were harvested for histopathology, flow cytometry and real time polymerase chain reaction (RT-PCR). The mice from BMT + MSC group had the best outcomes for survival rates (71.4% vs. 43.8%), renal scores (2.9% vs. 28.8% glomerular sclerosis) and percent splenic monocytes (4.2 vs. 11.3%) compared with mice from Rad Cont. Improvement in RAG and BMT groups was less prominent but were comparable with one another. Although MSC alone were not sufficient to control the renal pathology, it limited the expansion of CD4(-)CD8(-) T cell populations without a change in Foxp3 expression. The results suggest the importance of the innate immune system in disease pathogenesis and a role for MSC in immunomodulation.


Subject(s)
Bone Marrow Transplantation/immunology , Bone Marrow Transplantation/pathology , Bone Transplantation/immunology , Bone Transplantation/pathology , Immunity, Innate/immunology , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/surgery , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/pathology , Disease Models, Animal , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , Kaplan-Meier Estimate , Lupus Erythematosus, Systemic/pathology , Male , Mesoderm/metabolism , Mesoderm/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Stromal Cells/metabolism , Stromal Cells/pathology
7.
Lupus ; 13(12): 912-6, 2004.
Article in English | MEDLINE | ID: mdl-15645745

ABSTRACT

BXSB mice, a murine model of systemic lupus erythematosus (SLE), were treated with two different doses of fludarabine for a four-week period and examined two weeks after the final dose. Control mice were treated with saline or cyclophosphamide. Mice treated with fludarabine had a significant reduction in renal pathology compared to control mice. Fludarabine-treated mice also had an almost 10-fold increase in percentile of CD8+CD25+ T cells in the spleen and a smaller but significant increase in CD4+CD25+ cells. Mice treated with cyclophosphamide had a greater leucopenia compared to the other groups and a significant reduction in percentile of B220+ cells in peripheral blood and spleen. Serum autoantibody levels to dsDNA did not differ significantly among the groups, but were higher in 4/10 mice treated with fludarabine. Although few trials of fludarabine for human SLE have been conducted, additional studies may be warranted.


Subject(s)
Cyclophosphamide/therapeutic use , Immunosuppressive Agents/therapeutic use , Lupus Nephritis/drug therapy , Vidarabine/analogs & derivatives , Vidarabine/therapeutic use , Animals , Disease Models, Animal , Dose-Response Relationship, Drug , Drug Administration Schedule , Immunosuppressive Agents/administration & dosage , Kidney Glomerulus/drug effects , Kidney Glomerulus/pathology , Lupus Nephritis/pathology , Lymphocyte Count , Male , Mice , Spleen/drug effects , Spleen/pathology , Vidarabine/administration & dosage
11.
Adv Pediatr ; 48: 213-43, 2001.
Article in English | MEDLINE | ID: mdl-11480758

ABSTRACT

Inherited polyneuropathies present in the first 2 years of life are discussed with emphasis on clinical, pathologic, and molecular data. Early-onset polyneuropathies are relatively rare, sometimes life-threatening conditions that demand early recognition by clinical and pathologic examination. Histologic and ultrastructural overlaps among the various conditions are sometimes resolved by molecular genetic analysis. The growth in disease identification by genetic localization allows a more comprehensive understanding of the clinical and morphologic heterogeneity involving rearrangements of the same gene. Molecular mechanisms explaining the acquisition of such gene rearrangements are beginning to be unraveled. Peripheral myelin disorders may be confused with primary axonal disorders, and electrophysiologic examination often helps to distinguish between these two. Furthermore, early-onset central nervous system disorders may present as peripheral polyneuropathies and confound the clinical picture. A tentative diagnosis can often be offered by pathologic examination and confirmed by biochemical enzyme analysis later. The differential clinical diagnostic considerations of early-onset polyneuropathies are offered, to help clinicians sort out these diseases in the most efficient manner.


Subject(s)
Peripheral Nervous System Diseases/diagnosis , Chromosomes, Human, Pair 17/genetics , Diagnosis, Differential , Gene Duplication , Humans , Infant , Infant, Newborn , Peripheral Nervous System Diseases/classification , Peripheral Nervous System Diseases/genetics , Phenotype
15.
J Pediatr Hematol Oncol ; 21(6): 528-30, 1999.
Article in English | MEDLINE | ID: mdl-10598666

ABSTRACT

The authors report the concomitant occurrence of Duchenne muscular dystrophy (DMD) and alveolar rhabdomyosarcoma (RMS). A 4-year-old boy presented with symptoms involving his neuromuscular system that affected primarily his left hip and leg. Duchenne muscular dystrophy was diagnosed. Seven months later, metastatic alveolar RMS in the ipsilateral pelvis was documented. The diagnosis of one major disorder affecting striated muscle (DMD) may have prevented the early detection of another (RMS).


Subject(s)
Muscular Dystrophy, Duchenne/complications , Rhabdomyosarcoma, Alveolar/complications , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child, Preschool , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Etoposide/administration & dosage , Hematopoietic Stem Cell Transplantation , Humans , Ifosfamide/administration & dosage , Male , Mesna/administration & dosage , Muscular Dystrophy, Duchenne/diagnosis , Neoplasm Staging , Rhabdomyosarcoma, Alveolar/drug therapy , Rhabdomyosarcoma, Alveolar/pathology , Rhabdomyosarcoma, Alveolar/surgery , Vincristine/administration & dosage
17.
Nat Genet ; 23(2): 208-12, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10508519

ABSTRACT

Muscle contraction results from the force generated between the thin filament protein actin and the thick filament protein myosin, which causes the thick and thin muscle filaments to slide past each other. There are skeletal muscle, cardiac muscle, smooth muscle and non-muscle isoforms of both actin and myosin. Inherited diseases in humans have been associated with defects in cardiac actin (dilated cardiomyopathy and hypertrophic cardiomyopathy), cardiac myosin (hypertrophic cardiomyopathy) and non-muscle myosin (deafness). Here we report that mutations in the human skeletal muscle alpha-actin gene (ACTA1) are associated with two different muscle diseases, 'congenital myopathy with excess of thin myofilaments' (actin myopathy) and nemaline myopathy. Both diseases are characterized by structural abnormalities of the muscle fibres and variable degrees of muscle weakness. We have identified 15 different missense mutations resulting in 14 different amino acid changes. The missense mutations in ACTA1 are distributed throughout all six coding exons, and some involve known functional domains of actin. Approximately half of the patients died within their first year, but two female patients have survived into their thirties and have children. We identified dominant mutations in all but 1 of 14 families, with the missense mutations being single and heterozygous. The only family showing dominant inheritance comprised a 33-year-old affected mother and her two affected and two unaffected children. In another family, the clinically unaffected father is a somatic mosaic for the mutation seen in both of his affected children. We identified recessive mutations in one family in which the two affected siblings had heterozygous mutations in two different exons, one paternally and the other maternally inherited. We also identified de novo mutations in seven sporadic probands for which it was possible to analyse parental DNA.


Subject(s)
Actins/genetics , Muscle, Skeletal/metabolism , Muscular Diseases/genetics , Myopathies, Nemaline/genetics , Adolescent , Adult , Amino Acid Sequence , Amino Acid Substitution , Base Sequence , Child , Child, Preschool , DNA/chemistry , DNA/genetics , DNA Mutational Analysis , Family Health , Female , Humans , Infant , Male , Molecular Sequence Data , Mutation , Point Mutation , Polymorphism, Genetic , Polymorphism, Single-Stranded Conformational , Sequence Analysis, DNA , Sequence Homology, Amino Acid
18.
Pediatr Dev Pathol ; 2(2): 180-7, 1999.
Article in English | MEDLINE | ID: mdl-9949225

ABSTRACT

Seckel syndrome has been described as the prototype of the primordial bird-headed type of dwarfism. Since Seckel originally defined the disorder, less than 60 cases have been reported. In addition to the characteristic craniofacial dysmorphism and skeletal defects, abnormalities have been described in the cardiovascular, hematopoietic, endocrine, and central nervous systems. This pleiotropy has implied genetic heterogeneity and prompted reviews of previously reported cases of Seckel syndrome. As a result, the characteristic diagnostic features of Seckel syndrome have been highly debated. Although deletions in chromosome 2q have been described, to date, no genetic defect has been defined. We report three cases of Seckel-like syndrome in siblings from nonconsanguinous Caucasian parents. In addition to the typical Seckel phenotypic features, all three cases were characterized by severe hydrocephalus. We review the literature and propose that there is a spectrum of Seckel conditions that share some common key features, but also demonstrate a wide range of phenotypic features.


Subject(s)
Abnormalities, Multiple/pathology , Dwarfism/pathology , Family Health , Microcephaly/pathology , Abnormalities, Multiple/genetics , Dwarfism/genetics , Female , Genes, Recessive , Humans , Infant, Newborn , Intellectual Disability/genetics , Intellectual Disability/pathology , Karyotyping , Male , Microcephaly/genetics , Syndrome
19.
Bone Marrow Transplant ; 23(1): 91-3, 1999 Jan.
Article in English | MEDLINE | ID: mdl-10037057

ABSTRACT

A patient with aplastic anemia failed to respond to immunosuppressive therapy and first marrow transplantation (BMT). Recovery of autologous hematopoiesis was rapid following a second stem cell transplant with a non-myeloablative preparatory regimen. The autologous immune response to infectious mononucleosis (IM) 4 weeks post-transplant was normal despite recent and ongoing severe immunosuppression.


Subject(s)
Anemia, Aplastic/therapy , Bone Marrow Transplantation , Hematopoietic Stem Cell Transplantation , Infectious Mononucleosis/immunology , Child , Herpesvirus 4, Human/isolation & purification , Humans , Immunity, Innate , Immunosuppression Therapy , Infectious Mononucleosis/etiology , Male , Transplantation, Autologous
20.
Chest ; 114(4): 1220-3, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9792602

ABSTRACT

A 7-year-old boy with asthma was receiving the leukotriene receptor antagonist pranlukast (Ultair; SmithKline Beecham; Pittsburgh) as part of an open-label clinical trial. The patient's asthma improved, and he remained asymptomatic; but routine study evaluations 9 to 12 months into therapy showed microhematuria, proteinuria, glucosuria, anemia, and renal insufficiency. Renal biopsy demonstrated changes classic for acute allergic tubulointerstitial nephritis (ATIN), with mixed interstitial inflammatory infiltrate including eosinophils. Within 6 months of pranlukast withdrawal, anemia resolved and urinary sediment and renal function normalized. The case demonstrates that hypersensitivity reaction to pranlukast and resultant ATIN is possible, and that periodic urine testing in patients receiving pranlukast should be considered.


Subject(s)
Chromones/adverse effects , Leukotriene Antagonists/adverse effects , Nephritis, Interstitial/chemically induced , Acute Disease , Asthma/drug therapy , Biopsy , Child , Creatinine/blood , Follow-Up Studies , Glycosuria/etiology , Glycosuria/urine , Hematuria/etiology , Hematuria/urine , Humans , Male , Nephritis, Interstitial/metabolism , Nephritis, Interstitial/pathology , Proteinuria/etiology , Proteinuria/urine
SELECTION OF CITATIONS
SEARCH DETAIL
...